Pilgrim, whose device combines air sampling and genomic sequencing to detect biological threats, raised a $25M seed led by Buckley at a $150M valuation
Pilgrim has raised $25 million and has developed a 50-pound device that detects biological threats — Two Anthropic leaders are investing …
The company frames its initial platform, ARGUS, around airborne-pathogen detection and defense use; public reaction also centered on biological-security concerns and investment by Anthropic leaders. The seed financing gives Pilgrim a well-capitalized starting point for that field deployment proposition.
First-order effects
Pilgrim gains $25 million in seed financing, led by Buckley, to advance its 50-pound ARGUS detection platform at a $150 million valuation.
Pilgrim becomes a funded contender for defense-oriented biological-threat detection, rather than solely a developer of a diagnostic device.
Second-order effects
Biology-testing companies such as Spore.Bio face a clearer distinction between lab-speed tools and Pilgrim's field-deployed airborne surveillance proposition.
Defense and public-health buyers evaluating biological monitoring gain another prospective supplier whose system combines collection and sequencing in one device.
Third-order effects
If portable sequencing-based monitoring proves deployable, biological-threat detection may shift from episodic laboratory testing toward distributed, field-facing sensing systems.
The deal adds to a broader split in AI-for-biology investment between foundational models and operational tools that turn biological data into decisions outside the lab.
The trend: AI-enabled biology is expanding from research and laboratory workflows into deployable systems for detecting and responding to biological threats.
Browder Capital is thrilled to be a large pre-pre seed investor in Jake Adler from July 2022. Being an entrepreneur is like eating glass and Jake has overcome seemingly impossible challenges to develop his product and announce his $25m raise today. Congratulations to Jake and the…
3/ Spoke with @WSJ @KateClarkTweets about our $30M+ in total funding, our work with the CDC, and ARGUS, our first platform: a ~50-pound box designed to detect any airborne pathogen in near-real time. Initial deployments are underway. https://www.wsj.com/...
2/ Pilgrim is building America's first biology prime to bring those breakthroughs off the benchtop and into the battlefield. We engineer, manufacture and deploy advanced biotechnology for defense and national security.
1/ Biological threats can bring a country to a halt without a single shot being fired. Yet much of our biodefense infrastructure has barely changed in decades, even as America's institutions produce extraordinary scientific breakthroughs.
Anthropic leaders have invested in a startup developing technology to detect airborne viruses, amid growing fears that AI could lead to new biological threats. https://www.wsj.com/...
Building a bio-shield for humanity by ~2030 is one of the great quests (to use @_sholtodouglas' term) of our time. It's one of the biggest, most exciting technological challenges ever This is why I'm excited about @pilgrimlabs
New: Anthropic leaders have invested in a startup developing technology to detect airborne viruses, amid growing fears that AI could lead to new biological threats. …